Treatment of leukocytes from T2D patients with SS-31 reversed the protein level of p62 (Figure 3D; p < 0.05), while no changes were seen in the gene expression of SQSTM1/p62 suggesting that SS-31 can modify autophagy at protein level. This evidence concerns the gene SQSTM1 and type 2 diabetes mellitus.